| 摘要 |
The present invention relates to a composition for preventing or treating diseases associated with toll like receptor 2 (TLR 2), comprising triiodothyroacetic acid (TRIAC) as an active ingredient. The TRIAC inhibits the expression of an inflammatory factor such as p-ERK, p-p38 and p-JNK, and inhibits a TLR2 signal transmission system, thereby being efficiently used for preventing and treating TLR2-associated diseases such as atopic dermatitis, acute hepatitis, Kawasaki Disease, or allergy. |
